Cancer Research UK logo.
SearchDonate
  • Search

A trial of defactinib and pembrolizumab for people with solid tumours (FAK-PD1)

Overview

Cancer types:

All cancer types, Lung cancer, Mesothelioma, Non small cell lung cancer (NSCLC), Pancreatic cancer

Status:

Closed

Phase:

Phase 1/2

Details

This trial is for people with solid tumours that have spread or continued to grow despite other treatments (advanced cancer). A solid tumour is any type of cancer apart from those of the blood or lymphatic system such as:

  • leukaemia

  • lymphoma

  • myeloma

Cancer Research UK supports this trial.

Recruitment start: 18 May 2017

Recruitment end: 1 July 2022

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Christian Ottensmeier

Professor Jeff Evans

Professor Vicky Coyle

Dr Stefan Symeonides

Professor Dean Fennell

Supported by

Cancer Research UK

Cancer Clinical Trial Unit Scotland (CaCTUS)

MSD

NHS Greater Glasgow and Clyde

Queens’ University Belfast

University of Edinburgh

University of Glasgow

University of Leicester

University of Southampton

Verastem

Other information

This is Cancer Research UK trial number CRUKD/16/008

We have more information about Professor Dean Fennell.

Last reviewed: 17 July 2024

CRUK internal database number: 14132

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.